dioscin has been researched along with Carcinoma, Lewis Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Cui, L; Fang, L; Lu, G; Lu, S; Yang, G; Yao, Y; Ye, J; Zhou, J | 1 |
1 other study(ies) available for dioscin and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Dioscin elicits anti-tumour immunity by inhibiting macrophage M2 polarization via JNK and STAT3 pathways in lung cancer.
Topics: Animals; Carcinoma, Lewis Lung; Diosgenin; Macrophage Activation; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; STAT3 Transcription Factor; Tumor Microenvironment | 2020 |